Live Chat

Trade Bristol Myers BMY

BristolMyers live chart

Mga Pangunahing Kaalaman sa Instrumento

Weekly Search
Weekly
Daily
Petsa Isarado Pagbabago Change (%) Buksan High Low

Info

Spread

0.33

Spread (%)

0.6221 %

Leverage

1:10

Interes sa Magdamagang Pagbili

-0.0597 %

Interes sa Magdamagang Pagtinda

-0.0292 %

Currency

USD

Trading Hours

Oras ng Pagsasara

Lunes

13:31 - 19:59

Martes

13:31-19:59

Miyerkules

13:31-19:59

Huwebes

13:31-19:59

Biyernes

13:31-19:59

Analys och statistik

Buksan

---

Nakaraang Pagsara

---

52 Linggo Mataas/Mababa

--- – ---

Market Cap

113476673536

Natitirang Pagbabahagi

2028179968

Petsa ng Mga Kita (Susunod)

2001-08-07

Pambayad si dividend

2024-11-01

Araw ng Pag-alis ng Karapatan sa Dividend

2024-10-04

Inaasahang Taunang Rate ng Dividend

2.4

Inaasahang Taunang Dividend Yield

0.0433

EPS

-3.61

Alamin ang Higit Pa Tungkol sa Instrumentong ito

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Mga kaugnay na instrumento

view_all_instruments

Mga pinakabagong balita

Manatiling updated sa mga pinakabagong balitang pinansyal mula sa buong mundo.

Miyerkules, 6 Nobyembre 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Martes, 5 Nobyembre 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Martes, 5 Nobyembre 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Martes, 5 Nobyembre 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Martes, 5 Nobyembre 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Martes, 5 Nobyembre 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Lunes, 4 Nobyembre 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Lunes, 4 Nobyembre 2024

US election: What will happen to tesla stock if Trump wins?

Trustpilot
Live Chat